Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Korea SE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Chongkundang Holdings Corp

+ Add to Watchlist

001630:KS

60,400 KRW 1,200 2.03%

As of 19:27:19 ET on 02/01/2015.

Snapshot for Chongkundang Holdings Corp (001630)

Open: 59,200 Day's Range: 59,200 - 61,100 Volume: 5,914
Previous Close: 59,200 52wk Range: 41,700 - 87,100 1-Yr Rtn: +33.04%

Stock Chart for 001630

No chart data available.
  • 001630:KS 60,300
  • 1D
  • 1M
  • 1Y
59,200
Interactive 001630 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 001630

Current P/E Ratio (ttm) 1.5960
Estimated P/E(12/2014) -
Relative P/E vs. KOSPI 0.0561
Earnings Per Share (KRW) (ttm) 37,093.0000
Est. EPS (KRW) (12/2014) -
Est. PEG Ratio -
Market Cap (M KRW) 215,544.24
Shares Outstanding (M) 3.64
30 Day Average Volume 16,180
Price/Book (mrq) 1.4780
Price/Sale (ttm) 1.2317
Dividend Indicated Gross Yield 2.87%
Cash Dividend (KRW) 1,700.0000
Dividend Ex-Date 12/27/2013
5 Year Dividend Growth -
Next Earnings Announcement 02/23/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 001630

No data available

Company Profile & Key Executives for 001630

Chongkundang Holdings Corporation operates as a holding company. The Company, through its subsidiaries, manufactures pharmaceutical products and medical drugs in the fields of systemic anti-infective, cardiovascular system, alimentary tract, metabolism, and sensory organs.

Rhee Jang-HanChairmanKim Jung-WooVice Chairman/CEO/Rep Director
Kim Tae-YeongSenior Managing DirectorHa Seung-HoSenior Managing Director
More Company Profile & Key Executives for 001630

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
  • 001630 News

  • Industry News

No stories found
No stories found
Advertisement
Sponsored Links
Advertisements
sec ||= nil